๐ก๐ฒ๐๐ ๐ฆ๐๐บ๐บ๐ฎ๐ฟ๐
โข Lupin Limited has received approval from the US FDA for its Abbreviated New Drug Application for Ganirelix Acetate Injection, which will be manufactured at the company's Nagpur facility in India.
โข Ganirelix Acetate Injection is indicated for the inhibition of premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation.
โข The product had estimated annual sales of $84 million in the US and Lupin recently reported a 3.77-fold year-on-year rise in consolidated net profit for the July-September quarter.